✦ LIBER ✦

Comparison of the cost-effectiveness of upfront letrozole or anastrozole versus tamoxifen for early breast cancer in hormone receptor positive (HR+) postmenopausal women -the Cypriot perspective

✍ Scribed by D. Andreopoulos; J. Karnon; S. Kaura

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2062 POSTER Comparison of the cost-effec

✍ F. Di Trapani; J. Karnon; S. Kaura 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 79 KB

2092 POSTER Comparison of cost-effective

✍ K. El Ouagari; J. Karnon; S. Kaura 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 77 KB

P179 Comparison of the cost per distant

✍ J. Karnon; S. Kaura; F. di Trapani 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Cost utility analysis of early adjuvant

✍ Jonathan Karnon; Thomas Delea; Vicki Barghout 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 297 KB

Cost-Effectiveness of Letrozole Versus T

✍ Thomas E. Delea; Jon Karnon; Oleg Sofrygin; Simu K. Thomas; Natalie L. Papo; Vic 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 194 KB

Cost-effectiveness of letrozole versus t

✍ Thomas E. Delea; Khalid El-Ouagari; Jonathan Karnon; Oleg Sofrygin 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 301 KB